col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Endocrinology Research Centre

45 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Diabetes Mellitus 2024―Jan―10 Glucose metabolism disorders associated with COVID-19: clinical and morphological study T. L. Karonova, A. A. Mikhailova, D. I. Lagutina, O. M. Vorobeva, D. O. Grigoreva, K. A. Sterkhova, et al. (+5)
2 [GO] Diabetes Mellitus 2024―Jan―10 Efficacy and safety of glucagon-like peptide-1 receptor agonists therapy initiation in patients with type 2 diabetes hospitalized with coronavirus infection T. N. Markova, M. A. Lysenko, M. S. Stas, A. A. Anchutina
3 [GO] Problems of Endocrinology 2023―Sep―12 Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the <i>ACE2</i> gene, and therapy with RAS blockers on the severity of COVID-19 Z. T. Zuraeva, O. K. Vikulova, N. M. Malysheva, L. V. Nikankina, N. V. Zaytceva, O. Y. Sukhareva, et al. (+3)
4 [GO] Problems of Endocrinology 2023―Sep―12 Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy I. S. Maganeva, A. S. Bondarenko, A. P. Miliutina, A. R. Elfimova, E. E. Bibik, L. V. Nikankina, et al. (+3)
5 [GO] Diabetes Mellitus 2023―Sep―01 Organization of outpatient care for patients with diabetes mellitus in the context of the COVID-19 pandemic using telemedicine technologies V. V. Chichkova, M. A. Shapovalova, M. A. Chichkova, M. B. Antsiferov
6 [GO] Clinical and experimental thyroidology 2023―Aug―10 Difficulties in diagnosing subacute thyroiditis during COVID-19 pandemic V. V. Titova, T. Yu. Demidova, I. S. Chernysheva
7 [GO] Obesity and metabolism 2023―Jul―26 Factors influencing the severity of COVID-19 course for patients with diabetes mellitus in tashkent: a retrospective cohort study A. V. Alieva, A. A. Djalilov, F. A. Khaydarova, A. V. Alimov, D. Z. Khalilova, V. A. Talenova, et al. (+3)
8 [GO] Diabetes Mellitus 2023―Jul―18 Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage T. A. Nekrasova, L. G. Strongin, D. V. Belikina, E. S. Malysheva, A. A. Nekrasov
9 [GO] Obesity and metabolism 2023―May―24 Post-vaccination and post-infectious immune response against new coronavirus infection on the background of obesity and overweight A. V. Klimchuk, V. A. Beloglazov, I. A. Yatskov, Yu. M. Agzamova, A. A. Kamshii, A. A. Zayaeva
10 [GO] Clinical and experimental thyroidology 2023―Apr―20 Development of SARS-CoV-2 atypical thyroiditis in a patient with severe COVID-19 E. A. Kolpakova, А. А. Voznesenskaya, E. A. Metreveli, L. V. Nikankina, E. A. Troshina
11 [GO] Clinical and experimental thyroidology 2023―Apr―20 COVID-19 and the possible development of autoimmune thyroid diseases E. A. Kolpakova, A. R. Elfimova, L. V. Nikankina, I. N. Dyakov, K. K. Bushkova, E. A. Troshina
12 [GO] Obesity and metabolism 2023―Apr―17 The study of the dynamics of clinical and laboratory-instrumental parameters in hypertensive patients with obesity who underwent COVID-19-associated pneumonia T. I. Petelina, N. A. Musikhina, V. D. Garanina, A. E. Shcherbinina, K. S. Avdeeva, L. L. Valeeva, et al. (+8)
13 [GO] Problems of Endocrinology 2023―Feb―27 The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries V. V. Salukhov, G. P. Arutyunov, E. I. Tarlovskaya, T. I. Batluk, R. A. Bashkinov, I. V. Samus, et al. (+3)
14 [GO] Diabetes Mellitus 2023―Feb―09 Relationship between severe acute respiratory syndrome coronavirus 2 and diabetes mellitus (review) G. M. Artykbaeva, T. S. Saatov
15 [GO] Problems of Endocrinology 2023―Jan―26 The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries A. G. Arutyunov, E. I. Tarlovskaya, G. R. Galstyan, T. I. Batluk, R. A. Bashkinov, G. P. Arutyunov, et al. (+216)
16 [GO] Osteoporosis and Bone Diseases 2023―Jan―23 НИЗКОЭНЕРГЕТИЧЕСКИЕ ПЕРЕЛОМЫ У БОЛЬНЫХ С ПНЕВМОНИЕЙ, ВЫЗВАННОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИЕЙ COVID-19, И ИХ ВЛИЯНИЕ НА ПРОГНОЗ ЗАБОЛЕВАНИЯ Т. С. Семенова, С. О. Мазуренко, Л. Г. Ермолаева
17 [GO] Diabetes Mellitus 2022―Dec―02 Сarbohydrate metabolism disorders and their outcomes in the long-term period in hospitalized patients with COVID-19 V. V. Salukhov, A. A. Minakov, T. G. Sharypova, A. A. Kononova, V. A. Surkhaeva
18 [GO] Diabetes Mellitus 2022―Dec―02 Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020-2022 years: Russian nationwide retrospective study N. G. Mokrysheva, M. V. Shestakova, O. K. Vikulova, A. R. Elfimova, M. A. Isakov, N. A. Gins, et al. (+2)
19 [GO] Problems of Endocrinology 2022―Nov―07 Pituitary and COVID-19: review U. V. Buyvalenko, M. A. Perepelova, R. A. Zolotareva, Zh. E. Belaya, G. A. Melnichenko
20 [GO] Diabetes Mellitus 2022―Oct―04 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia F. A. Khaydarova, A. V. Alieva, D. M. Berdikulova, N. U. Alimova, D. Z. Khalilova, I. M. Tojieva
21 [GO] Problems of Endocrinology 2022―Sep―15 Androgenic status in men during COVID-19 R. V. Rozhivanov, G. A. Melnichenko, E. N. Andreeva, N. G. Mokrysheva
22 [GO] Obesity and metabolism 2022―Sep―08 Endocrine disorders in the background of COVID-19 and postcovid syndrome A. V. Klimchuk, V. A. Beloglazov, I. A. Yatskov, Ya. V. Dvoryanchikov
23 [GO] Problems of Endocrinology 2022―Jul―16 Hypophysitis and reversible hypopituitarism developed after COVID-19 infection - a clinical case report N. Yu. Gorbova, V P. Vladimirova, L. Y. Rozhinskaya, Zh. Y. Belaya
24 [GO] Problems of Endocrinology 2022―Apr―30 Dysglycemia in COVID-19 and Type 2 Diabetes Mellitus: Peculiarities of the Glycemic Profile in Hospitalized Patients and the Role of Steroid-Induced Disorders L. G. Strongin, T. A. Nekrasova, D. V. Belikina, K. G. Korneva, A. V. Petrov
25 [GO] Diabetes Mellitus 2022―Mar―23 Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists I. I. Dedov, N. G. Mokrysheva, M. Vladimirovna Shestakova, T. V. Nikonova, A. Yu. Mayorov, G. R. Galstyan, et al. (+20)
26 [GO] Diabetes Mellitus 2022―Mar―23 Impact of COVID-19 infection on the development of type 1 diabetes mellitus in children and adolescents F. A. Khaydarova, N. U. Alimova, A. V. Alieva, A. S. Sadykova, M. D. Aripova
27 [GO] Obesity and metabolism 2022―Feb―21 Obesity and covid-19 - signs of convergence of two pandemiсs. Guidelines to fight obesity based on the principles of «ROOTS» A. B. Fursov, O. B. Ospanov, R. A. Fursov
28 [GO] Problems of Endocrinology 2021―Nov―12 SARS-CoV-2 morbidity depending on vitamin D status T. L. Karonova, A. T. Andreeva, K. A. Golovatyuk, E. S. Bykova, I. I. Skibo, E. N. Grineva, E. V. Shlyakhto
29 [GO] Diabetes Mellitus 2021―Sep―30 Clinical characteristics of patients with COVID-19 depending on the treatment received and the presence of type 2 diabetes mellitus K. G. Lobanova, T. Y. Demidova, S. N. Perekhodov, M. B. Antsiferov
30 [GO] Diabetes Mellitus 2021―Sep―30 Prevalence of carbohydrate metabolism disorders in patients with new coronavirus infection T. N. Markova, M. A. Lysenko, A. A. Ivanova, E. S. Pavlova, A. A. Ponomareva, V. V. Chibisova, et al. (+3)
31 [GO] Problems of Endocrinology 2021―Sep―17 Current state of the obesity research: genetic aspects, the role of microbiome, and susceptibility to COVID-19 Ya. R. Timasheva, Zh. R. Balkhiyarova, O. V. Kochetova
32 [GO] Clinical and experimental thyroidology 2021―Mar―18 Translation of the ESE statement concerning COVID-19 vaccination sent to all Presidents of the ESE Council of Affiliated Societies Article Editorial
33 [GO] Obesity and metabolism 2021―Mar―06 Peculiarities of the COVID-19 course and consequences in overweight and obese patients. Lessons from the current pandemic T. Yu. Demidova, E. I. Volkova, E. Yu. Gritskevich
34 [GO] Diabetes Mellitus 2021―Feb―15 Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease E. M. Zeltyn-Abramov, M. A. Lysenko, N. F. Frolova, T. N. Markova, N. I. Belavina, N. N. Klochkova, et al. (+3)
35 [GO] Diabetes Mellitus 2021―Feb―15 High level of glycated hemoglobin (HbA1c) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus M. V. Shestakova, I. V. Kononenko, Z. A. Kalmykova, A. V. Zheleznyakova, N. G. Mokrysheva
36 [GO] Problems of Endocrinology 2020―Dec―08 The role of HLA genes: from autoimmune diseases to COVID-19 Ekaterina A. Troshina, Marina Yu. Yukina, Nurana F. Nuralieva, Natalia G. Mokrysheva
37 [GO] Problems of Endocrinology 2020―Dec―08 Androgens and Antiandrogens influence on COVID-19 disease in men Roman V. Rozhivanov, Elena N. Andreeva, Galina A. Melnichenko, Natalya G. Mokrysheva
38 [GO] Clinical and experimental thyroidology 2020―Nov―30 Adaptation of the hypothalamo-pituitary-thyroid and hypothalamo-pituitary-adrenal systems to a new infectious disease - COVID-19 in the development of COVID-19 pneumonia and/or cytokine storm Ekaterina Troshina, Galina Melnichenko, Evgeniya Senyushkina, Natalia Mokrysheva
39 [GO] Problems of Endocrinology 2020―Sep―16 Screening for gestational diabetes due to of the COVID-19 pandemic Ayarpi O. Torosyan, Ekaterina V. Loginova, Chelebi G. Gagaev
40 [GO] Diabetes Mellitus 2020―Aug―10 Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 Z. A. Kalmykova, I. V. Kononenko, I. A. Sklyanik, M. V. Shestakova, N. G. Mokrysheva
41 [GO] Diabetes Mellitus 2020―Aug―10 COVID-19 and kidneys M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova
42 [GO] Diabetes Mellitus 2020―Aug―10 The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus O. K. Vikulova, Zamira Zuraeva, L. V. Nikankina, M. V. Shestakova
43 [GO] Diabetes Mellitus 2020―Jun―27 Course and treatment of diabetes mellitus in the context of COVID-19 Marina V. Shestakova, Natalya G. Mokrysheva, Ivan I. Dedov
44 [GO] Problems of Endocrinology 2020―Jun―07 Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the Russian Diabetes Registry. Marina V Shesnakova Shtsnakova, Vikulova Vikulova, Mikhail Isakov, Ivan Dedov
45 [GO] Problems of Endocrinology 2020―May―09 COVID-19 pandemic and endocrinopathies. Natalia G. Mokrysheva, Gagik R. Galstyan, Michael A. Kirzhakov, Anna K. Eremkina, Galina A. Melnichenko
 [1] 

45 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.020 sec